Additional European Equity News

Anglo American (AAL LN) - De Beers rough diamond sales, cycle-1, USD 660mln. Saw a continuation of the robust rough diamond demand in the cycle. (Newswires)

BioNTech (22UA GY)/Pfizer (PFE) - Initiates rolling submission for EUA of COVID-19 vaccine in children 6 months through 4 years of age following a request from US FDA. (Pfizer)

Credit Agricole (ACA FP) - Generali (G IM) agreed to acquire Credit Agricole's health insurance unit for EUR 435mln. (Newswires)

Credit Suisse (CSGN SW) - US judge has refused to dismiss a class-action suit from investors which accuses the Co. of conspiring to rig prices in the FX market. (Newswires)

Energy Names - UK PM Johnson is set to unveil billions of GBP in state-backed loans to lower the impact of rising energy prices on households. (Telegraph)

Glencore (GLEN LN) FY21 Production Report - Copper 1.195k/T (prev. 1.258k/T), Cobalt 31k/T (prev. 27.4k/T), Gold 809k/oz (prev. 916k/oz), Silver 31.52k/oz (prev. 32.77k/oz), Coal 103.3mln/T (prev. 106.2mln/T). FY22 production guidance is unchanged from the December update. (Glencore)

GSK (GSK LN) announces settlement between ViiV Healthcare (joint venture by Pfizer and GlaxoSmithKline) and Gilead Sciences, Inc. resolving litigation relating to Biktarvy and ViiV’s dolutegravir patents and entry into a patent licence agreement. Gilead will make an upfront payment of USD 1.25bln to ViiV Healthcare in Q1 2022. (GSK)

Hexagon (HEXAB SS) Q4 (EUR) - Sales 1.22bln (exp. 1.21bln), adj. EBIT 373mln (exp. 362mln), EPS 0.11 (prev. 0.092). (Newswires)

Novartis (NOVN SW) - Several PE firms are reportedly considering bids up to USD 25bln for the Sandoz unit, according to sources. Blackstone/Carlyle and EQT named. (FT)

Novo Nordisk (NOVOB DC) Q4/FY (DKK) - Q4: Revenue 38.3bln (exp. 37.9bln), EBIT 13.63bln (exp. 14.36bln). FY: Revenue 140.8bln (exp. 140.1bln), North American sales 10%, International sales +12%. Intends to initiate a new 12-month buyback programme of up to 22bln. (Newswires)

Orsted (ORSTED DC) Q4/FY (DKK) - Q4: EBITDA 8.25bln (exp. 8.59bln). FY: Net Income 10.89bln (exp. 10.82bln). Recommends a 12.5/shr dividend, +87%. Expects onshore and offshore earnings for FY22 to be significantly higher YY. (Newswires)

Playtech (PTEC LN) - FY21 results expected to exceed prior expectations. Aristocrat says the offer to acquire Playtech is expected to lapse, votes cast in favour were short of the 75% threshold required. Playtech says it is to hold a meeting today on the deal, actively considering options for maximising value and evaluating alternative proposals they have received. (Newswires)

Ryanair (RYA LN) - January load factor 79%, 46.4k flights operated. (Newswires)

Roche (ROG SW) - Head of Pharma Research & Early Development Pao is leaving to join Pfizer (PFE). (Newswires)

Saipem (SPM IM) - Board has picked Rothschild to advise on the creation of required financial restructuring; among the possible options, they could convert part of a credit line with banks but lenders are reportedly 'cold' on such a proposal, via Il Sole/Il Messaggero. (Newswires)

Sanofi (SAN FP)/Regeneron (REGN) - Positive Dupixent data across five diseases with underlying type 2 inflammation to be presented at 2022 AAAAI Annual Meeting. (Regeneron)

Severn Trent (SVT LN) Trading Update - No material changes to current year business performance/outlook since the November interim update. (Newswires)

Telenor (TEL NO) Q4 (NOK) - Revenue 28.2bln (exp. 28.08bln), adj. EBITDA 11.74bln (exp. 12.15bln), pretax profit 2.98bln (exp. 4.78bln). In Asia, pressure remains on the top-line due to intense competition and the COVID impact. Propose a dividend of 9.30/shr, in-line with the dividend policy. (Newswires)

Vodafone (VOD LN) Q3 Trading Update (EUR) – Revenue 11.7bln (prev. 11.2bln). Good performance in-line with expectations and on track to attain FY22 guidance. (Newswires)

Wizz Air (WIZZ LN) - January load factor 79.6%. (Newswires)

02 Feb 2022 - 07:05- EquitiesData- Source: Newsquawk